Biocorrx (BICX) Projected to Post Earnings on Wednesday

Biocorrx (OTCMKTS:BICX) is projected to issue its results before the market opens on Wednesday, February 25th. Analysts expect the company to announce earnings of ($0.06) per share and revenue of $0.20 million for the quarter.

Biocorrx Price Performance

Biocorrx stock opened at $0.35 on Tuesday. Biocorrx has a 52-week low of $0.20 and a 52-week high of $0.50. The company has a market cap of $8.57 million, a P/E ratio of -1.09 and a beta of 0.41. The business has a 50-day simple moving average of $0.32 and a two-hundred day simple moving average of $0.36.

Biocorrx Company Profile

BioCorRx Inc, through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States. It distributes and licenses BioCorRx recovery program, a non-addictive and medication-assisted treatment program that includes a counseling program coupled with its proprietary naltrexone implant; and distributes UnCraveRx weight loss management program, a medically assisted weight management program to reduce food cravings combined with on-demand virtual lifestyle support, fitness, and nutrition.